In-hospital outcomes after rotational atherectomy in patients with low ejection fraction

References

• Brodie BR, Stuckey T, Downey W, et al. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. JACC Cardiovasc Interv. 2008;1:405–414.
   PubMed Web of Science ®Google Scholar
• Otsuka M, Toyofuku M, Watanabe N, et al. Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease. EuroIntervention. 2011;6:754–759.
   PubMed Web of Science ®Google Scholar
• Smits PC, Kedhi E, Royaards KJ, et al. 2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTE stent in all-comers: a randomized open label trial). J Am Coll Cardiol. 2011;58:11–18.
   PubMed Web of Science ®Google Scholar
• Raber L, Juni P, Nuesch E, et al. Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization. J Am Coll Cardiol. 2011;57:2143–2151.
   PubMed Web of Science ®Google Scholar
• Taniwaki M, Stefanini GG, Silber S, et al. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2014;63:1617–1625.
   PubMed Web of Science ®Google Scholar
• Fujimoto H, Nakamura M, Yokoi H. Impact of calcification on the long-term outcomes of sirolimus-eluting stent implantation: subanalysis of the Cypher Post-Marketing Surveillance Registry. Circ J. 2012;76:57–64.
   PubMed Web of Science ®Google Scholar
• Fujii K, Mintz GS, Kobayashi Y, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation. 2004;109: 1085–1088.
   PubMed Web of Science ®Google Scholar
• Hong MK, Mintz GS, Lee CW, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:1305–1310.
   PubMed Web of Science ®Google Scholar
• Stertzer SH, Rosenblum J, Shaw RE, et al. Coronary rotational ablation: initial experience in 302 procedures. J Am Coll Cardiol. 1993;21:287–295.
   PubMed Web of Science ®Google Scholar
• Warth DC, Leon MB, O'Neill W, et al. Rotational atherectomy multicenter registry: acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol. 1994;24:641–648.
   PubMed Web of Science ®Google Scholar
• Reisman M, Harms V, Whitlow P, et al. Comparison of early and recent results with rotational atherectomy. J Am Coll Cardiol. 1997;29:353–357.
   PubMed Web of Science ®Google Scholar
• Ahn SS, Auth D, Marcus DR, et al. Removal of focal atheromatous lesions by angioscopically guided high-speed rotary atherectomy. Preliminary experimental observations. J Vasc Surg. 1988;7:292–300.
   PubMed Web of Science ®Google Scholar
• Ritchie JL, Hansen DD, Intlekofer MJ, et al. Rotational approaches to atherectomy and thrombectomy. Zeitschrift Fur Kardiol. 1987;76(Suppl 6):59–65.
   PubMedGoogle Scholar
• Couper LT, Loane P, Andrianopoulos N, et al. Utility of rotational atherectomy and outcomes over an eight-year period. Catheter Cardiovasc Interv. 2015.
   PubMed Web of Science ®Google Scholar
• Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.
   PubMed Web of Science ®Google Scholar
• Romagnoli E, Burzotta F, Trani C, et al. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart (British Cardiac Society). 2009;95:43–48.
   PubMed Web of Science ®Google Scholar
• Jinnouchi H, Kuramitsu S, Shinozaki T, et al. Two-year clinical outcomes of newer-generation drug-eluting stent implantation following rotational atherectomy for heavily calcified lesions. Circ J. 2015;79:1938–1943.
   PubMed Web of Science ®Google Scholar
• Edes IF, Ruzsa Z, Szabo G, et al. Clinical predictors of mortality following rotational atherectomy and stent implantation in high-risk patients: A single center experience. Cathet Cardiovasc Intervent. 2015;86:634–641.
   PubMed Web of Science ®Google Scholar
• Chambers JW, Feldman RL, Himmelstein SI, et al. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). JACC Cardiovasc Interv. 2014;7:510–518.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86:64–70.
   PubMed Web of Science ®Google Scholar
• Gilutz H, Weinstein JM, Ilia R. Repeated balloon rupture during coronary stenting due to a calcified lesion: an intravascular ultrasound study. Cathet Cardiovasc Intervent. 2000;50:212–214.
   PubMed Web of Science ®Google Scholar
• Onuma Y, Tanimoto S, Ruygrok P, et al. Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study. Cathet Cardiovasc Intervent. 2010;76:634–642.
   PubMed Web of Science ®Google Scholar
• Wu C, Hannan EL, Walford G, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006;47:654–660.
   PubMed Web of Science ®Google Scholar